Investment opportunity

We are looking for funding in order to move forward with our research and development. Read more below.

Investment opportunity

404 - Page was not found

Sivua eng/investors/basic-information ei löytynyt tältä sivustolta

Search results

Investors(Page)
Information for investors Tietoa sijoittajille The company calls for additional investors Medicortex Finland Plc is giving current shareholder...

Medicortex presentation in Monaco (News)
Additional information regarding the presentation by Dr. Adrian Harel from Medicortex Finland Oy in Monaco (September 28, 2018 - Novo...

Last Reminder to Holders of Incentive Options(News)
your e-mails for detailed information, or contact us to get the information. If no action is taken by the option holder until the due date...

Why invest?(Page)
nt of the diagnostic kit. Basic development including preclinical trial and proof-of-concept human testing has been done. The company has co...

Second clinical trial(Page)
inical Trial Picture More information about the study is available at ClinicalTrials.gov/NCT03306563 . The objective of the second clinical tr...

Reports and presentations (Page)
rities system). Financial information The latest approved Financial statement and auditor's report: Medicortex Tilinpaatos 2022 Medicortex Fin...

Board of Directors(Page)
apy, drug development and basic research. Additionally, in his last position, before Medicortex, he was the CEO of BrainStorm Cell Therapeutic...

Board of Directors(Page)
apy, drug development and basic research. Additionally, in his last position, before Medicortex, he was the CEO of BrainStorm Cell Therapeutic...

Team(Page)
ciences and life sciences basic research.  Scientific Writer, Dr. Leonardo Lara-Valderrábano has a PhD in Neuropharmacology, with a post-docto...

Invest Now(Page)
ustration only Note: This information may not be published or distributed directly or indirectly in the United States, Australia, Canada, Hong...

Why Invest?(Page)
ustration only Note: This information may not be published or distributed directly or indirectly in the United States, Australia, Canada, Ho...

Medicortex Finland Held Discussions with TEKES(News)
y presented their updated information and future plans...

Medicortex presentation in Monaco (News)
eting in Monaco. For more information please look at the link. ...

Medicortex Finland Oy: Clinical Trial Extended for Detection of Mild Traumatic Brain Injury(News)
nnish hospitals. For more information please look at the link. ...

Third study site has been added to the clinical trial (News)
The latest information regarding the clinical trial has been updated to the...

Medicortex Announces Receiving a 1.1 Million Dollars Research Grant from the US Department of Defense / Medicortex Finland Oy:lle tutkimusrahoitusta Yhdysvaltain Puolustusministeriöltä(News)
release for detailed information. Medicortex:lle myönnettiin 1,1 milj.$ apuraha Yhdysvaltain Puolustusministeriöltä...

Medicortex is looking for new investors (News)
estor’s page for more information. ...

Share price now 6.40 euro / Osakkeen hinta nyt 6,40 euroa(News)
criptions. Please see the information on our Investors pages.Alkaen 12...

Medicortex is having a campaign 5 – 20 January 2023(News)
p style="">For additional information, please visit our...

Medicortex subscription campaign ends 20.1.2023 // Medicortex osakeanti päättyy 20.1.2023!(News)
ktie!More information and subscription agreement are...

Medicortex has a fundraising campaign 10-24.5.2023(News)
ess!For additional information, please visit our investors...

Medicortex's new brain injury test: share issue 14 - 28 November 2023(News)
000 € (1 € / share). More information here...

Medicortexin osakeanti päättyy huomenna / Medicortex's share issue ends tomorrow(News)
w brain injury test! More information here...